<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bryant R England, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ted R Mikuls, MD, MSPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James R O'Dell, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Philip Seo, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 16, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1554584259"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by an inflammatory polyarthritis that preferentially affects the small joints. RA is a "multicausal" disease that most likely results from a combination of genetic predisposition and various environmental and lifestyle factors. Articular and systemic manifestations in RA can lead to poor long-term outcomes such as disability and death.</p><p>The epidemiology, risk factors, and causes of RA will be reviewed here. The pathogenesis, genetic basis, clinical manifestations, diagnosis, and treatment are presented separately. (See  <a class="medical medical_review" href="/d/html/7513.html" rel="external">"Pathogenesis of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/d/html/7487.html" rel="external">"HLA and other susceptibility genes in rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/d/html/7502.html" rel="external">"Clinical manifestations of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/d/html/7511.html" rel="external">"Overview of the systemic and nonarticular manifestations of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/d/html/7504.html" rel="external">"Diagnosis and differential diagnosis of rheumatoid arthritis"</a> and  <a class="medical medical_review" href="/d/html/7516.html" rel="external">"General principles and overview of management of rheumatoid arthritis in adults"</a> and  <a class="medical medical_review" href="/d/html/7491.html" rel="external">"Initial treatment of rheumatoid arthritis in adults"</a>.)</p><p class="headingAnchor" id="H3957884214"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Rheumatoid arthritis (RA) is estimated to affect approximately 0.24 to 1 percent of the population and to be twice as common in women compared with men. A range of poor long-term outcomes can potentially occur, but these have been reduced to some degree with the use of more aggressive treatment strategies and more effective drug therapies. However, RA's financial burden on society remains substantial. (See <a class="local">'Incidence and prevalence'</a> below and <a class="local">'Long-term outcomes'</a> below and <a class="local">'Economic burden'</a> below.)</p><p class="headingAnchor" id="H3522489713"><span class="h2">Incidence and prevalence</span><span class="headingEndMark"> — </span>The worldwide prevalence of RA has been estimated as 0.24 percent based upon the Global Burden of Disease 2010 Study [<a href="#rid1">1</a>]. Estimates of RA prevalence in the United States and northern European countries are typically higher, usually between 0.5 to 1 percent [<a href="#rid2">2,3</a>]. The annual incidence of RA in the United States and northern European countries is estimated to be approximately 40 per 100,000 persons [<a href="#rid2">2,4</a>]. Most epidemiologic studies of RA have been conducted in United States or northern European populations. As a result, epidemiologic estimates of RA and identification of risk factors come largely from these populations. The incidence and prevalence of RA is much greater in some populations, such as in the Pima Native Americans, where rates are up to 10 times higher than those of most population groups [<a href="#rid5">5</a>].</p><p>RA has a predilection to affect women, in whom incidence and prevalence rates of RA are twice as high as in men. The lifetime risk of developing RA is 3.6 percent in women and 1.7 percent in men [<a href="#rid6">6</a>].</p><p>It is uncertain whether the incidence and prevalence of RA is changing over time. The incidence of RA increased from 1995 to 2007 in Olmstead County, Minnesota after declining over the prior four decades [<a href="#rid2">2</a>]. In the United Kingdom, the incidence of RA decreased an average of 1.6 percent per year from 1990 to 2014 [<a href="#rid7">7</a>]. From 1990 to 2010, the worldwide prevalence of RA appears to be stable [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H1992061048"><span class="h2">Long-term outcomes</span><span class="headingEndMark"> — </span>Patients with RA are at risk of developing several adverse long-term outcomes, although these outcomes can be improved by early identification and early, aggressive treatment with disease-modifying antirheumatic drugs (DMARDs). These long-term complications can include:</p><p class="bulletIndent1"><span class="glyph">●</span>Physical and work disability – Impairment in physical function leads to near-universal reporting of difficulty with valued life activities [<a href="#rid8">8</a>]. Nearly 40 percent of patients with RA will have work disability within 10 years of diagnosis [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reduced quality of life – Patients with RA have lower physical and mental health-related quality of life compared with the general population [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Joint replacement surgeries – Up to 25 percent of patients with RA will have a joint replacement in the 20 years after disease onset [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/d/html/7478.html" rel="external">"Surgical management of end-stage rheumatoid arthritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Development of other chronic diseases – RA increases the risk of many chronic diseases including cardiovascular disease [<a href="#rid12">12</a>], lung diseases [<a href="#rid13">13,14</a>], psychiatric disorders [<a href="#rid15">15</a>], osteoporosis and fractures [<a href="#rid16">16</a>], and some malignancies (eg, lymphoma, lung and nonmelanoma skin cancers) [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Premature mortality – Survival is reduced in RA compared with the general population, with cardiovascular disease, respiratory disease, and cancer being the leading causes of death in RA [<a href="#rid18">18,19</a>].</p><p></p><p>Temporal trends show improving long-term outcomes. The prognosis of RA has improved substantially in association with treatment advances, including the earlier initiation of DMARD therapies, implementation of treat-to-target strategies, and the expansion of effective therapeutic options [<a href="#rid20">20,21</a>]. However, studies examining whether survival in RA has improved relative to improvements in the general population are conflicting, and results can vary by the cause of death [<a href="#rid22">22-24</a>].</p><p class="headingAnchor" id="H4122083243"><span class="h2">Economic burden</span><span class="headingEndMark"> — </span>RA poses a substantial burden to health care systems and society. Regular health care visits, long-term treatment with DMARDs, increased disability and work loss, reduced quality of life, and premature mortality result in total (direct, indirect, and intangible) annual societal costs estimated to exceed $39 billion 2005 United States dollars [<a href="#rid25">25</a>]. A similar economic burden has been suggested by studies from several European countries, although the individual contribution of drug costs, other medical costs, and indirect costs to these totals varies substantially by country [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H3079013540"><span class="h1">RISK FACTORS FOR AND POTENTIAL CAUSES OF RA</span><span class="headingEndMark"> — </span>A series of genetic, demographic, lifestyle, environmental, and physiologic risk factors for rheumatoid arthritis (RA) have been identified in epidemiologic and related studies, though many have not been externally validated and appear to have small effect sizes. (See <a class="local">'Familial and genetic risk factors'</a> below and <a class="local">'Demographic risk factors'</a> below and <a class="local">'Lifestyle factors'</a> below and <a class="local">'Environmental risk factors'</a> below and <a class="local">'Physiologic risk factors or identifiers of preclinical RA'</a> below.)</p><p class="headingAnchor" id="H1355919587"><span class="h2">Familial and genetic risk factors</span><span class="headingEndMark"> — </span>Familial and genome-wide association studies have provided evidence of the hereditability of RA and identified genetic risk loci, as emphasized by the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history</strong> – A large, Swedish nested case-control study estimated RA hereditability to be 40 percent [<a href="#rid27">27</a>]. Familial risk was higher for seropositive and early-onset RA. A family history of RA affected the risk of RA as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>First-degree relative (eg, mother, father, sibling) – Threefold higher odds</p><p class="bulletIndent2"><span class="glyph">•</span>Second-degree relative (eg, grandparent, aunt, uncle) – Twofold higher odds</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetics</strong> – Over 100 risk loci for RA have been identified, primarily in studies of White populations [<a href="#rid28">28</a>]. The genetics of RA is described in more detail separately. (See  <a class="medical medical_review" href="/d/html/7487.html" rel="external">"HLA and other susceptibility genes in rheumatoid arthritis"</a>.)</p><p></p><p class="bulletIndent1">Briefly, the following associations are of particular note:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Human leukocyte antigen (HLA)-DRB1 – The strongest genetic predisposition for RA is within the HLA-DRB1 region. Within the HLA-DRB1 region, a shared sequence of amino acids at positions 70 to 74 termed the "shared epitope" has been consistently identified as a risk factor for RA [<a href="#rid29">29</a>]. Further studies have identified 16 HLA-DRB1 haplotypes based upon amino acid positions 11, 71, and 74 in the HLA-DRB1 region that may better predict RA risk and disease course than shared epitope status [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/d/html/7487.html" rel="external">"HLA and other susceptibility genes in rheumatoid arthritis", section on 'HLA alleles and susceptibility to rheumatoid arthritis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other susceptibility genes – Several genetic loci outside of the HLA-DRB1 region affect the predisposition to developing RA [<a href="#rid28">28</a>]. These include protein tyrosine phosphatase N22 (<em>PTPN22</em>), <em>STAT4</em>, <em>TRAF1-C5</em>, <em>PADI4</em>, and <em>CTLA4</em>, among others. (See  <a class="medical medical_review" href="/d/html/7487.html" rel="external">"HLA and other susceptibility genes in rheumatoid arthritis", section on 'Rheumatoid arthritis severity genes outside the HLA region'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Interactions between HLA-DRB1 and non-HLA genes – An analysis of genome-wide association data from two independent case-control studies identified interactions between HLA-DRB1 shared epitope alleles and a large number of non-HLA single-nucleotide polymorphisms for the risk of anti-citrullinated protein antibody (ACPA)-positive RA [<a href="#rid31">31</a>].</p><p></p><p class="headingAnchor" id="H1703749181"><span class="h2">Demographic risk factors</span><span class="headingEndMark"> — </span>Demographic factors associated with a higher risk of RA include older age, female sex, North American and Western European ethnicities and selected smaller ethnic groups, and lower socioeconomic status:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Age</strong> – RA typically occurs in middle-aged and older individuals with peak incidence rates between the ages of 65 and 80 years [<a href="#rid2">2,4</a>]. "Elderly-onset RA" (diagnosed after age 60 to 65 years) is often accompanied by constitutional symptoms and proximal joint involvement [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sex</strong> – Incidence rates of RA are nearly twice as high among females compared with males [<a href="#rid2">2</a>]. Expression of disease varies by sex, with males more likely to develop extraarticular features such as subcutaneous nodules and interstitial lung disease [<a href="#rid33">33</a>]. The degree to which these sex differences relate to differences in environmental factors such as cigarette smoking remains unknown.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Geographic regions and populations</strong> – Globally, RA is most common in Australasian, Western Europe, and North American regions and least common in east/southeast Asia and North Africa/the Middle East [<a href="#rid1">1</a>]. Among the highest rates of RA observed have been in Native Americans, including the Pima [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Socioeconomic status</strong> – Lower socioeconomic status and education levels are associated with a higher risk of RA [<a href="#rid34">34,35</a>].</p><p></p><p class="headingAnchor" id="H2594418725"><span class="h2">Lifestyle factors</span><span class="headingEndMark"> — </span>Cigarette smoking, poor diet quality, obesity, and physical inactivity are lifestyle factors that may increase RA risk. The effect of these lifestyle factors, as well as genetic risk alleles discussed, may be mediated at least in part by epigenetic changes such as deoxyribonucleic acid (DNA) methylation and histone modifications among others [<a href="#rid36">36</a>]. (See <a class="local">'Cigarette smoking'</a> below and <a class="local">'Other lifestyle factors'</a> below.)</p><p class="headingAnchor" id="H3604823785"><span class="h3">Cigarette smoking</span><span class="headingEndMark"> — </span>Cigarette smoking is the strongest known lifestyle or environmental risk factor for RA [<a href="#rid37">37</a>]. The dose-dependent relationship between cigarette smoking and RA is more closely linked to seropositive RA and interacts with the presence of shared epitope alleles [<a href="#rid38">38-40</a>]. The relative risks (RR) for ACPA-positive RA in a Swedish study, analyzed based upon smoking history and shared epitope allele presence and copy number, were [<a href="#rid38">38</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Never smoker, negative shared epitope – Referent group</p><p class="bulletIndent1"><span class="glyph">●</span>Ever smoker, negative shared epitope – RR 1.5 (95% CI 0.8-2.6)</p><p class="bulletIndent1"><span class="glyph">●</span>Never smoker, one copy shared epitope – RR 3.3 (95% CI 1.8-5.9)</p><p class="bulletIndent1"><span class="glyph">●</span>Ever smoker, one copy shared epitope – RR 6.5 (95% CI 3.8-11.4)</p><p class="bulletIndent1"><span class="glyph">●</span>Never smoker, two copies shared epitope – RR 5.4 (95% CI 2.7-10.8)</p><p class="bulletIndent1"><span class="glyph">●</span>Ever smoker, two copies shared epitope – RR 21.0 (95% CI 11.0-40.2)</p><p></p><p>There is conflicting evidence on whether passive cigarette smoke exposure increases the risk of developing RA, with childhood passive smoke exposure being more closely linked to RA risk [<a href="#rid41">41-43</a>]. In addition to the well-described gene-smoking interaction and the consistency of observations linking cigarette smoking to RA risk [<a href="#rid37">37</a>], other factors supporting a causal role of smoking in RA development include: (1) the induction of citrullination in the lungs by cigarette smoking [<a href="#rid44">44</a>], (2) identification of RA autoantibodies in bronchoalveolar fluid [<a href="#rid45">45</a>] and identification of RA autoantibodies in individuals with chronic lung diseases and without RA [<a href="#rid46">46,47</a>], and (3) risk reduction that follows long term smoking cessation [<a href="#rid48">48-50</a>]. (See <a class="local">'Modifiable risk factors'</a> below.)</p><p class="headingAnchor" id="H1635750594"><span class="h3">Other lifestyle factors</span><span class="headingEndMark"> — </span>The association of other lifestyle factors with RA risk is less well established for most of these exposures or habits than it is for cigarette use:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alcohol</strong> – Moderate intake of alcohol has been associated with a lower risk of RA in some [<a href="#rid51">51,52</a>], but not all [<a href="#rid53">53</a>], cohort studies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutrition and diet</strong> – Observational studies of diet and RA risk have been inconclusive. Adherence to a higher-quality diet and higher intake of fish and long-chain n-3 polyunsaturated fatty acids may be associated with a modestly lower risk of RA [<a href="#rid54">54-56</a>]. Adhering specifically to a Mediterranean diet is not associated with a lower risk of RA [<a href="#rid57">57,58</a>]. There are conflicting results regarding coffee increasing RA risk [<a href="#rid59">59-61</a>], antioxidants lowering RA risk [<a href="#rid62">62,63</a>], and consumption of red meat increasing RA risk [<a href="#rid64">64,65</a>]. Consumption of sugar-sweetened soda was associated with a higher risk of RA in the Nurses' Health Studies [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vitamin D intake</strong> – There are conflicting findings regarding a possible inverse association between vitamin D intake and RA risk [<a href="#rid67">67,68</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical activity</strong> – Higher levels of leisure-time physical activity may be associated with a lower risk of RA, though this has not been consistently observed [<a href="#rid53">53,69</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obesity</strong> – Several observational studies have suggested that obesity is a risk factor for RA. A meta-analysis of 11 observational studies estimated a 30 percent increased risk of RA for individuals with an obese body mass index (BMI &gt;30 kg/m<sup>2</sup>) and 15 percent increased risk for those with an overweight BMI (25 to 29.9 kg/m<sup>2</sup>) versus those with normal body weight [<a href="#rid70">70</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hormonal and reproductive factors</strong> – Breast feeding has been associated with a lower risk of RA, while parity and oral contraceptives are not significantly associated with RA risk [<a href="#rid71">71,72</a>]. Conflicting findings have been reported in other cohorts [<a href="#rid73">73</a>]. Early age at menopause has been reported to confer higher RA risk, and menopausal factors are more closely related to seronegative RA risk [<a href="#rid74">74,75</a>]. In post-hoc analyses from the Women's Health Initiative randomized trial, there were nonsignificant trends towards lower RA risk with postmenopausal hormone therapy [<a href="#rid76">76</a>]. In men, lower testosterone levels have been associated with a higher risk of seronegative RA [<a href="#rid77">77</a>].</p><p></p><p class="headingAnchor" id="H1063073010"><span class="h2">Environmental risk factors</span><span class="headingEndMark"> — </span>Chronic mucosal inflammation, particularly of the oral mucosa and the lung; microbial dysbiosis and bacterial and viral infections; and inhalant exposures are environmental risk factors associated with increased risk for RA. (See <a class="local">'Chronic inflammatory mucosal conditions'</a> below and <a class="local">'Infections'</a> below and <a class="local">'Occupational exposures and inhalants'</a> below and <a class="local">'Psychologic and other factors'</a> below.)</p><p class="headingAnchor" id="H1874956073"><span class="h3">Chronic inflammatory mucosal conditions</span><span class="headingEndMark"> — </span>Chronic inflammation of mucosal sites, including the oral mucosa and lung, appears to be a risk factor for RA. Evidence from a large case-control study with detailed periodontal exams and adjustment for several confounders demonstrated 35 percent higher likelihood of the presence of periodontitis in RA compared with patients with osteoarthritis [<a href="#rid78">78</a>]. However, cohort studies have suffered from inconsistent approaches of classifying periodontitis and from limited adjustments for confounders [<a href="#rid79">79,80</a>].</p><p>RA autoantibody responses have been detected in the serum of patients with bronchiectasis and cystic fibrosis in the absence of RA [<a href="#rid46">46,47</a>]. Airway abnormalities are significantly more common in high-risk individuals (those with RA autoantibodies but without inflammatory arthritis) than controls [<a href="#rid81">81</a>].</p><p class="headingAnchor" id="H2153943483"><span class="h3">Infections</span><span class="headingEndMark"> — </span>There has long been interest in identifying infections that may trigger the onset of RA. Building off a growing understanding of chronic inflammation of mucosal sites driving autoimmunity, studies of the microbiome and its interface with mucosal immunity have been of particular interest. The following microbial and infection-related findings are of note:</p><p class="bulletIndent1"><span class="glyph">●</span>Dysbiosis of mucosal sites – Periodontal, gut, and distal airway microbial dysbiosis occurs more commonly in RA patients than controls [<a href="#rid82">82,83</a>]. While global dysbiosis (ie, perturbation of normal bacterial flora) has been more consistently identified as a risk factor than specific individual pathogens, several candidate bacterial pathogens have been reported in RA.</p><p></p><p class="bulletIndent1">In the oral cavity, candidate pathogens have included <em>Porphyromonas gingivalis</em>, Prevotella species, and <em>Aggregatibacter actinomycetemcomitans</em>, among others [<a href="#rid84">84-86</a>]. <em>P. gingivalis</em> is of particular interest since this pathogen expresses a peptidylarginine deiminase that may drive citrullination of peptides and ACPA responses. The most consistent individual bacterial pathogen identified in gut microbiome studies in RA is <em>Prevotella copri </em>[<a href="#rid87">87,88</a>]. A 2022 study implicated the Lachnospiraceae/Ruminococcaceae genus <em>Subdoligranulum</em> as another gut microbe that has the potential to drive initial tolerance loss in RA [<a href="#rid89">89</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Viral infections – Polyarthritis can accompany many viral infections, including those related to parvovirus B19, hepatitis B and C, and rubella, providing plausibility that viral infections could serve as triggers of RA. Molecular mimicry has been proposed as a potential link between Epstein-Barr virus (EBV) and RA, with EBV-encoded proteins sharing homology with the shared epitope and ACPAs from patients with RA targeting citrullinated EBV-encoded peptides [<a href="#rid90">90,91</a>]. However, a meta-analysis of 23 case-control studies of EBV serologies and RA did not find a consistent association [<a href="#rid92">92</a>]. Outbreaks of Chikungunya virus have demonstrated a high prevalence of infected patients developing persistent inflammatory arthritis, including cases of seropositive, erosive RA [<a href="#rid93">93</a>]. It is unknown whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination may affect RA risk [<a href="#rid94">94,95</a>]. Other viruses implicated as risk factors for RA are parvovirus B19, rubella, cytomegalovirus, and human T-lymphotropic virus type 1. (See  <a class="medical medical_review" href="/d/html/3024.html" rel="external">"Chikungunya fever: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/127933.html" rel="external">"COVID-19: Care of adult patients with systemic rheumatic disease"</a> and  <a class="medical medical_review" href="/d/html/5614.html" rel="external">"Viral arthritis: Causes and approach to evaluation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other infections – Greater serologic responses to <em>Mycoplasma pneumoniae</em>, <em>Proteus mirabilis</em>, and <em>Escherichia coli</em> have also been reported in RA compared with controls [<a href="#rid96">96,97</a>].</p><p></p><p class="headingAnchor" id="H2359926260"><span class="h3">Occupational exposures and inhalants</span><span class="headingEndMark"> — </span>A range of airborne inhalant exposures has been associated with increased risk for RA:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational</strong> – Occupations with exposure to airborne inhalants, including silica, appear to confer greater risk of RA, especially in men [<a href="#rid98">98,99</a>]. Prolonged work exposure at the World Trade Center site following the 9/11 attacks was associated with greater risk of developing autoimmune disease, the most common of which was RA [<a href="#rid100">100,101</a>]. Farming and exposure to chemical fertilizers and solvents have also been associated with increased RA risk [<a href="#rid102">102,103</a>]. Select military inhalant exposures have also been associated with autoantibody expression and RA risk in United States veterans [<a href="#rid104">104,105</a>]. Occupational inhalant exposures appear to interact with genetic risk factors and/or cigarette smoking to potentiate RA risk [<a href="#rid104">104,106</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pollution</strong> – Residential proximity to traffic has been associated with higher risk of RA [<a href="#rid107">107,108</a>]. However, exposure to air pollution measured by particulate matter and gaseous pollutants has not been consistently associated with disease risk in all studies [<a href="#rid109">109,110</a>].</p><p></p><p class="headingAnchor" id="H1545486449"><span class="h3">Psychologic and other factors</span><span class="headingEndMark"> — </span>Other proposed risk factors for RA have included stress, including post-traumatic stress disorder, and selected medications, including statins:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psychologic factors</strong> – Stress is thought to dysregulate the immune system, and supporting this notion, individuals with post-traumatic stress disorder have been found to have an increased risk of developing RA [<a href="#rid111">111,112</a>]. One prospective study found that higher levels of perceived stress were associated with an increased risk of developing inflammatory arthritis among ACPA-positive individuals, all of whom were without active arthritis at study enrollment [<a href="#rid113">113</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Statins</strong> – There are conflicting data regarding whether statins (HMG-CoA reductase inhibitors) influence the risk of RA, with both higher and lower risk of RA reported [<a href="#rid114">114,115</a>]. Treatment with <a class="drug drug_general" data-topicid="8949" href="/d/drug information/8949.html" rel="external">atorvastatin</a> did not prevent the development of clinical arthritis in autoantibody-positive individuals with arthralgias in a small randomized trial [<a href="#rid116">116</a>].</p><p></p><p class="headingAnchor" id="H2290237896"><span class="h2">Physiologic risk factors or identifiers of preclinical RA</span><span class="headingEndMark"> — </span>Autoantibodies and inflammatory responses characteristic of RA can be detected in the blood prior to RA onset; these may be considered risk factors, but more likely represent the early biologic processes that precede and subsequently lead to clinically apparent RA. This phase of disease, when RA autoantibodies are detected but inflammatory arthritis is not present, has been termed "preclinical RA" or "prediagnostic RA," and these individuals are thought to be at high risk for developing the clinical disorder. The following changes have been observed:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Autoantibodies</strong> – Rheumatoid factor (RF), an antibody to the Fc portion of an immunoglobulin G (IgG), and ACPAs are the two autoantibodies of primary clinical relevance in RA. The specificity of commercially available anti-cyclic citrullinated peptide (anti-CCP) antibodies and RF for the diagnosis of RA are 95 and 85 percent respectively [<a href="#rid117">117</a>]. These autoantibodies are detectable in the blood on average 3 to 5 years (ranging to &gt;12 years) prior to the development of clinically apparent RA [<a href="#rid118">118,119</a>]. Anti-CCP positivity appears to have greater predictive ability for the onset of RA than RF. While the specificity of these autoantibodies is high for RA prior to disease onset, positive predictive values in the general population are modest given the low prevalence of RA.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic inflammation</strong> – Proinflammatory cytokine production accompanies the expansion of ACPA responses and also precedes RA onset [<a href="#rid120">120</a>]. Given very low specificity, there is little clinical utility in measuring acute phase responses (C-reactive protein or erythrocyte sedimentation rate) for predicting the onset of RA [<a href="#rid121">121</a>].</p><p></p><p class="headingAnchor" id="H2493280547"><span class="h1">PREVENTION OF RA</span><span class="headingEndMark"> — </span>Given the potentially poor long-term outcomes and substantial economic burden posed by rheumatoid arthritis (RA), there is considerable interest in developing strategies aimed at disease prevention. Two approaches that have been proposed are targeting of modifiable risk factors and administering preventive immunomodulating therapies in individuals at high risk for developing RA. (See <a class="local">'Modifiable risk factors'</a> below and <a class="local">'Clinical trials examining preventive therapies'</a> below.)</p><p class="headingAnchor" id="H2515179517"><span class="h2">Modifiable risk factors</span><span class="headingEndMark"> — </span>Independent observational studies have found that smoking cessation lowers the risk of RA over time, though the rates still appear to be modestly higher 20 to 30 years after quitting than for lifetime nonsmokers [<a href="#rid48">48-50</a>]. Data suggesting that addressing other modifiable risk factors might also lower RA risk are lacking.</p><p>Thus, research is needed to determine which individuals likely to be at increased risk of RA (based upon genetics, family history, and environmental exposures) should be targeted for risk factor modification measures, and what strategies might be effective in modifying those factors; there will then also be a need to assess what the outcomes of such strategies are for general health and for the development of RA.</p><p>In pursuit of such efforts, behaviors that might reduce the likelihood of RA in at-risk individuals and that are of general health benefit include:</p><p class="bulletIndent1"><span class="glyph">●</span>Smoking cessation</p><p class="bulletIndent1"><span class="glyph">●</span>Eating a well-balanced diet</p><p class="bulletIndent1"><span class="glyph">●</span>Achieving and maintaining a healthy body weight</p><p class="bulletIndent1"><span class="glyph">●</span>Regular physical activity</p><p class="bulletIndent1"><span class="glyph">●</span>Good dental hygiene and regular dental visits</p><p class="bulletIndent1"><span class="glyph">●</span>Wearing respiratory protective equipment when exposed to potentially noxious inhalants</p><p></p><p>Given challenges that patients often have in adopting and maintaining these behaviors, there is a need for strategies to improve adoption of healthy behaviors, including in individuals at risk of RA. As an example of one approach, a randomized trial, involving 238 subjects, showed that use of a web-based risk estimator for RA, personalized with genotype/biomarker results and behaviors, increased motivation to improve behaviors among first-degree relatives of patients with RA who did not have the disease themselves [<a href="#rid122">122</a>].</p><p class="headingAnchor" id="H769438630"><span class="h2">Clinical trials examining preventive therapies</span><span class="headingEndMark"> — </span>Trials evaluating drug therapies to prevent RA are ongoing that typically identify individuals at high risk for RA based upon the presence of RA autoantibodies in the absence of inflammatory arthritis; however, these trials have had inconclusive results. The implications of these trials for other risk reduction efforts are uncertain. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>Glucocorticoids – A randomized trial comparing an intramuscular injection of 100 mg of <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a> and placebo in 83 individuals with arthralgias and positive RA autoantibodies found no difference in the rate of developing RA over a median follow-up of 26 months [<a href="#rid123">123</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9616" href="/d/drug information/9616.html" rel="external">Rituximab</a> – In the PRAIRI study, a randomized trial assessing a single infusion of 1000 mg of rituximab for the prevention of RA in 81 individuals with RA autoantibodies but no arthritis, rituximab delayed the onset of RA by 12 months but did not significantly decrease the risk of developing RA over a mean follow-up of 29 months [<a href="#rid124">124</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8949" href="/d/drug information/8949.html" rel="external">Atorvastatin</a> – The STAPRA trial was a randomized trial that evaluated the ability of atorvastatin to prevent the onset of clinical arthritis in patients with RA autoantibodies and arthralgias [<a href="#rid116">116</a>]. While this trial was stopped early due to insufficient patient recruitment, atorvastatin did not show any protective effect.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9630" href="/d/drug information/9630.html" rel="external">Methotrexate</a> – In the TREAT EARLIER trial, which included 236 patients with arthralgias who were suspected of progressing to RA based on magnetic resonance imaging (MRI)-detected subclinical joint inflammation, patients who were randomly assigned to receive a single intramuscular glucocorticoid injection plus a one-year course of oral methotrexate had similar rates of developing clinical arthritis compared with those who took placebo, up to one year after the one-year treatment period (19 percent in the treatment group versus 18 percent in the placebo group; hazard ratio 0.81 [95% CI 0.45-1.48]) [<a href="#rid125">125</a>]. However, there were greater improvements in physical functioning, pain, morning stiffness, and MRI-detected joint inflammation in the treatment group, which supports the role of methotrexate as an effective disease-modifying treatment among patients in the early phases of the disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8541" href="/d/drug information/8541.html" rel="external">Hydroxychloroquine</a> – Interim results from the STOP RA trial, a double-blind, randomized controlled trial of one year of hydroxychloroquine treatment in adults who were anti-cyclic citrullinated peptide 3 (anti-CCP3) positive but lacked inflammatory arthritis (n = 144) did not reveal efficacy for preventing or delaying RA onset [<a href="#rid126">126</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8526" href="/d/drug information/8526.html" rel="external">Abatacept</a> – The double-blind, randomized, controlled APIPPRA trial found that one year of abatacept treatment in autoantibody positive adults with arthralgias (n = 213 randomized) reduced the incidence of inflammatory arthritis while on treatment. However, after discontinuing treatment, incidence rates approached those in the placebo group [<a href="#rid127">127</a>].</p><p></p><p class="headingAnchor" id="H1096297681"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Rheumatoid arthritis (RA) affects 0.2 to 1 percent of the developed world’s population and is a multicausal disease resulting from genetic predisposition and various lifestyle and environmental factors. (See <a class="local">'Incidence and prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcomes</strong> – Long-term outcomes that can affect patients with RA include disability, reduced quality of life, a need for joint replacement surgery, development of other chronic conditions, and premature mortality. (See <a class="local">'Long-term outcomes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic risk factors</strong> – Human leukocyte antigen (HLA)-DRB1 genes represent the strongest genetic risk factor for RA, and having a first-degree relative with RA increases the risk of RA approximately threefold. (See <a class="local">'Familial and genetic risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Environmental risk factors</strong> – Cigarette smoking represents the strongest environmental risk factor for RA and interacts with HLA-DRB1 shared epitope alleles to markedly increase the risk of anti-citrullinated protein antibody (ACPA)-positive RA. (See <a class="local">'Cigarette smoking'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiome risk factors</strong> – Mucosal inflammation and dysbiosis of the periodontal, gut, and lung microbiota may represent disease risk factors and could be involved in the evolution of early generation of RA-related autoimmunity at extraarticular sites. (See <a class="local">'Chronic inflammatory mucosal conditions'</a> above and <a class="local">'Infections'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – The identification of RA autoantibodies (rheumatoid factor [RF] and ACPA) may herald the future onset of RA and has allowed studies of high-risk individuals aimed at RA prevention. However, optimal strategies for reducing the risk of RA are not known; smoking cessation is important in risk reduction and healthy lifestyle behaviors are likely to be beneficial. (See <a class="local">'Prevention of RA'</a> above.)</p><p></p><p class="headingAnchor" id="H1063527660"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Peter Schur, MD, Cynthia S Crowson, PhD, and Sherine Gabriel, MD, MSc, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014; 73:1316.</a></li><li><a class="nounderline abstract_t">Myasoedova E, Crowson CS, Kremers HM, et al. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010; 62:1576.</a></li><li><a class="nounderline abstract_t">Hunter TM, Boytsov NN, Zhang X, et al. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int 2017; 37:1551.</a></li><li><a class="nounderline abstract_t">Eriksson JK, Neovius M, Ernestam S, et al. Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res (Hoboken) 2013; 65:870.</a></li><li><a class="nounderline abstract_t">Del Puente A, Knowler WC, Pettitt DJ, Bennett PH. High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 1989; 129:1170.</a></li><li><a class="nounderline abstract_t">Crowson CS, Matteson EL, Myasoedova E, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 2011; 63:633.</a></li><li><a class="nounderline abstract_t">Abhishek A, Doherty M, Kuo CF, et al. Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study. Rheumatology (Oxford) 2017; 56:736.</a></li><li><a class="nounderline abstract_t">Katz PP, Morris A, Yelin EH. Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis. Ann Rheum Dis 2006; 65:763.</a></li><li><a class="nounderline abstract_t">Eberhardt K, Larsson BM, Nived K, Lindqvist E. Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time. J Rheumatol 2007; 34:481.</a></li><li><a class="nounderline abstract_t">Matcham F, Scott IC, Rayner L, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum 2014; 44:123.</a></li><li><a class="nounderline abstract_t">Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998; 41:1072.</a></li><li><a class="nounderline abstract_t">Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012; 71:1524.</a></li><li><a class="nounderline abstract_t">Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010; 62:1583.</a></li><li><a class="nounderline abstract_t">Sparks JA, Lin TC, Camargo CA Jr, et al. Rheumatoid arthritis and risk of chronic obstructive pulmonary disease or asthma among women: A marginal structural model analysis in the Nurses' Health Study. Semin Arthritis Rheum 2018; 47:639.</a></li><li><a class="nounderline abstract_t">Marrie RA, Hitchon CA, Walld R, et al. Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2018; 70:970.</a></li><li><a class="nounderline abstract_t">Xue AL, Wu SY, Jiang L, et al. Bone fracture risk in patients with rheumatoid arthritis: A meta-analysis. Medicine (Baltimore) 2017; 96:e6983.</a></li><li><a class="nounderline abstract_t">Simon TA, Thompson A, Gandhi KK, et al. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 2015; 17:212.</a></li><li><a class="nounderline abstract_t">England BR, Sayles H, Michaud K, et al. Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2016; 68:36.</a></li><li><a class="nounderline abstract_t">Sparks JA, Chang SC, Liao KP, et al. Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses' Health Study. Arthritis Care Res (Hoboken) 2016; 68:753.</a></li><li><a class="nounderline abstract_t">Krishnan E, Lingala B, Bruce B, Fries JF. Disability in rheumatoid arthritis in the era of biological treatments. Ann Rheum Dis 2012; 71:213.</a></li><li><a class="nounderline abstract_t">Aga AB, Lie E, Uhlig T, et al. Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010. Ann Rheum Dis 2015; 74:381.</a></li><li><a class="nounderline abstract_t">Myasoedova E, Gabriel SE, Matteson EL, et al. Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA? J Rheumatol 2017; 44:732.</a></li><li><a class="nounderline abstract_t">Dadoun S, Zeboulon-Ktorza N, Combescure C, et al. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine 2013; 80:29.</a></li><li><a class="nounderline abstract_t">Johnson TM, Yang Y, Roul P, et al. A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2023; 75:1648.</a></li><li><a class="nounderline abstract_t">Birnbaum H, Pike C, Kaufman R, et al. Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin 2010; 26:77.</a></li><li><a class="nounderline abstract_t">Furneri G, Mantovani LG, Belisari A, et al. Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis. Clin Exp Rheumatol 2012; 30:S72.</a></li><li><a class="nounderline abstract_t">Frisell T, Holmqvist M, Källberg H, et al. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age. Arthritis Rheum 2013; 65:2773.</a></li><li><a class="nounderline abstract_t">Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014; 506:376.</a></li><li><a class="nounderline abstract_t">Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30:1205.</a></li><li><a class="nounderline abstract_t">Raychaudhuri S, Sandor C, Stahl EA, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012; 44:291.</a></li><li><a class="nounderline abstract_t">Diaz-Gallo LM, Ramsköld D, Shchetynsky K, et al. Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis. Ann Rheum Dis 2018; 77:1454.</a></li><li><a class="nounderline abstract_t">Pease CT, Bhakta BB, Devlin J, Emery P. Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors. Rheumatology (Oxford) 1999; 38:228.</a></li><li><a class="nounderline abstract_t">Weyand CM, Schmidt D, Wagner U, Goronzy JJ. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum 1998; 41:817.</a></li><li><a class="nounderline abstract_t">Ghawi H, Crowson CS, Rand-Weaver J, et al. A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case-control study. BMJ Open 2015; 5:e006469.</a></li><li><a class="nounderline abstract_t">Bengtsson C, Nordmark B, Klareskog L, et al. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005; 64:1588.</a></li><li><a class="nounderline abstract_t">Nair N, Wilson AG. Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis. Expert Rev Clin Immunol 2023; 19:483.</a></li><li><a class="nounderline abstract_t">Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2010; 69:70.</a></li><li><a class="nounderline abstract_t">Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54:38.</a></li><li><a class="nounderline abstract_t">Karlson EW, Chang SC, Cui J, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2010; 69:54.</a></li><li><a class="nounderline abstract_t">Alfredsson L, Klareskog L, Hedström AK. Influence of Smoking on Disease Activity and Quality of Life in Patients With Rheumatoid Arthritis: Results From a Swedish Case-Control Study With Longitudinal Follow-Up. Arthritis Care Res (Hoboken) 2023; 75:1269.</a></li><li><a class="nounderline abstract_t">Hedström AK, Klareskog L, Alfredsson L. Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study. Ann Rheum Dis 2018; 77:970.</a></li><li><a class="nounderline abstract_t">Yoshida K, Wang J, Malspeis S, et al. Passive Smoking Throughout the Life Course and the Risk of Incident Rheumatoid Arthritis in Adulthood Among Women. Arthritis Rheumatol 2021; 73:2219.</a></li><li><a class="nounderline abstract_t">Seror R, Henry J, Gusto G, et al. Passive smoking in childhood increases the risk of developing rheumatoid arthritis. Rheumatology (Oxford) 2019; 58:1154.</a></li><li><a class="nounderline abstract_t">Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008; 67:1488.</a></li><li><a class="nounderline abstract_t">Reynisdottir G, Karimi R, Joshua V, et al. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2014; 66:31.</a></li><li><a class="nounderline abstract_t">Quirke AM, Perry E, Cartwright A, et al. Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis. Arthritis Rheumatol 2015; 67:2335.</a></li><li><a class="nounderline abstract_t">Janssen KM, de Smit MJ, Brouwer E, et al. Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study. Arthritis Res Ther 2015; 17:174.</a></li><li><a class="nounderline abstract_t">Di Giuseppe D, Orsini N, Alfredsson L, et al. Cigarette smoking and smoking cessation in relation to risk of rheumatoid arthritis in women. Arthritis Res Ther 2013; 15:R56.</a></li><li><a class="nounderline abstract_t">Liu X, Tedeschi SK, Barbhaiya M, et al. Impact and Timing of Smoking Cessation on Reducing Risk of Rheumatoid Arthritis Among Women in the Nurses' Health Studies. Arthritis Care Res (Hoboken) 2019; 71:914.</a></li><li><a class="nounderline abstract_t">Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62:835.</a></li><li><a class="nounderline abstract_t">Di Giuseppe D, Alfredsson L, Bottai M, et al. Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study. BMJ 2012; 345:e4230.</a></li><li><a class="nounderline abstract_t">Lu B, Solomon DH, Costenbader KH, Karlson EW. Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective study. Arthritis Rheumatol 2014; 66:1998.</a></li><li><a class="nounderline abstract_t">Cerhan JR, Saag KG, Criswell LA, et al. Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women. J Rheumatol 2002; 29:246.</a></li><li><a class="nounderline abstract_t">Di Giuseppe D, Wallin A, Bottai M, et al. Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women. Ann Rheum Dis 2014; 73:1949.</a></li><li><a class="nounderline abstract_t">Di Giuseppe D, Crippa A, Orsini N, Wolk A. Fish consumption and risk of rheumatoid arthritis: a dose-response meta-analysis. Arthritis Res Ther 2014; 16:446.</a></li><li><a class="nounderline abstract_t">Hu Y, Sparks JA, Malspeis S, et al. Long-term dietary quality and risk of developing rheumatoid arthritis in women. Ann Rheum Dis 2017; 76:1357.</a></li><li><a class="nounderline abstract_t">Hu Y, Costenbader KH, Gao X, et al. Mediterranean diet and incidence of rheumatoid arthritis in women. Arthritis Care Res (Hoboken) 2015; 67:597.</a></li><li><a class="nounderline abstract_t">Johansson K, Askling J, Alfredsson L, et al. Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study. Arthritis Res Ther 2018; 20:175.</a></li><li><a class="nounderline abstract_t">Heliövaara M, Aho K, Knekt P, et al. Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis 2000; 59:631.</a></li><li><a class="nounderline abstract_t">Mikuls TR, Cerhan JR, Criswell LA, et al. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2002; 46:83.</a></li><li><a class="nounderline abstract_t">Karlson EW, Mandl LA, Aweh GN, Grodstein F. Coffee consumption and risk of rheumatoid arthritis. Arthritis Rheum 2003; 48:3055.</a></li><li><a class="nounderline abstract_t">Cerhan JR, Saag KG, Merlino LA, et al. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 2003; 157:345.</a></li><li><a class="nounderline abstract_t">Costenbader KH, Kang JH, Karlson EW. Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol 2010; 172:205.</a></li><li><a class="nounderline abstract_t">Benito-Garcia E, Feskanich D, Hu FB, et al. Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study. Arthritis Res Ther 2007; 9:R16.</a></li><li><a class="nounderline abstract_t">Pattison DJ, Symmons DP, Lunt M, et al. Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 2004; 50:3804.</a></li><li><a class="nounderline abstract_t">Hu Y, Costenbader KH, Gao X, et al. Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women. Am J Clin Nutr 2014; 100:959.</a></li><li><a class="nounderline abstract_t">Costenbader KH, Feskanich D, Holmes M, et al. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67:530.</a></li><li><a class="nounderline abstract_t">Merlino LA, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004; 50:72.</a></li><li><a class="nounderline abstract_t">Di Giuseppe D, Bottai M, Askling J, Wolk A. Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study. Arthritis Res Ther 2015; 17:40.</a></li><li><a class="nounderline abstract_t">Qin B, Yang M, Fu H, et al. Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis. Arthritis Res Ther 2015; 17:86.</a></li><li><a class="nounderline abstract_t">Karlson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004; 50:3458.</a></li><li><a class="nounderline abstract_t">Pikwer M, Bergström U, Nilsson JA, et al. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 2009; 68:526.</a></li><li><a class="nounderline abstract_t">Orellana C, Saevarsdottir S, Klareskog L, et al. Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2017; 76:1845.</a></li><li><a class="nounderline abstract_t">Pikwer M, Bergström U, Nilsson JÅ, et al. Early menopause is an independent predictor of rheumatoid arthritis. Ann Rheum Dis 2012; 71:378.</a></li><li><a class="nounderline abstract_t">Bengtsson C, Malspeis S, Orellana C, et al. Association Between Menopausal Factors and the Risk of Seronegative and Seropositive Rheumatoid Arthritis: Results From the Nurses' Health Studies. Arthritis Care Res (Hoboken) 2017; 69:1676.</a></li><li><a class="nounderline abstract_t">Walitt B, Pettinger M, Weinstein A, et al. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. Arthritis Rheum 2008; 59:302.</a></li><li><a class="nounderline abstract_t">Pikwer M, Giwercman A, Bergström U, et al. Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study. Ann Rheum Dis 2014; 73:573.</a></li><li><a class="nounderline abstract_t">Mikuls TR, Payne JB, Yu F, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 2014; 66:1090.</a></li><li><a class="nounderline abstract_t">Arkema EV, Karlson EW, Costenbader KH. A prospective study of periodontal disease and risk of rheumatoid arthritis. J Rheumatol 2010; 37:1800.</a></li><li><a class="nounderline abstract_t">Chou YY, Lai KL, Chen DY, et al. Rheumatoid Arthritis Risk Associated with Periodontitis Exposure: A Nationwide, Population-Based Cohort Study. PLoS One 2015; 10:e0139693.</a></li><li><a class="nounderline abstract_t">Demoruelle MK, Weisman MH, Simonian PL, et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012; 64:1756.</a></li><li><a class="nounderline abstract_t">Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 2015; 21:895.</a></li><li><a class="nounderline abstract_t">Scher JU, Joshua V, Artacho A, et al. The lung microbiota in early rheumatoid arthritis and autoimmunity. Microbiome 2016; 4:60.</a></li><li><a class="nounderline abstract_t">Mikuls TR, Thiele GM, Deane KD, et al. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 2012; 64:3522.</a></li><li><a class="nounderline abstract_t">Scher JU, Ubeda C, Equinda M, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012; 64:3083.</a></li><li><a class="nounderline abstract_t">Konig MF, Abusleme L, Reinholdt J, et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med 2016; 8:369ra176.</a></li><li><a class="nounderline abstract_t">Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013; 2:e01202.</a></li><li><a class="nounderline abstract_t">Maeda Y, Kurakawa T, Umemoto E, et al. Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine. Arthritis Rheumatol 2016; 68:2646.</a></li><li><a class="nounderline abstract_t">Chriswell ME, Lefferts AR, Clay MR, et al. Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum. Sci Transl Med 2022; 14:eabn5166.</a></li><li><a class="nounderline abstract_t">Pratesi F, Tommasi C, Anzilotti C, et al. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum 2006; 54:733.</a></li><li><a class="nounderline abstract_t">Roudier J, Petersen J, Rhodes GH, et al. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci U S A 1989; 86:5104.</a></li><li><a class="nounderline abstract_t">Ball RJ, Avenell A, Aucott L, et al. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis. Arthritis Res Ther 2015; 17:274.</a></li><li><a class="nounderline abstract_t">Bouquillard E, Combe B. Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases. Ann Rheum Dis 2009; 68:1505.</a></li><li><a class="nounderline abstract_t">Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, et al. Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis 2021; 80:1096.</a></li><li><a class="nounderline abstract_t">Baimukhamedov C, Barskova T, Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol 2021; 3:e324.</a></li><li><a class="nounderline abstract_t">Ramírez AS, Rosas A, Hernández-Beriain JA, et al. Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: a case-control study. Rheumatology (Oxford) 2005; 44:912.</a></li><li><a class="nounderline abstract_t">Newkirk MM, Goldbach-Mansky R, Senior BW, et al. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology (Oxford) 2005; 44:1433.</a></li><li><a class="nounderline abstract_t">Ilar A, Alfredsson L, Wiebert P, et al. Occupation and Risk of Developing Rheumatoid Arthritis: Results From a Population-Based Case-Control Study. Arthritis Care Res (Hoboken) 2018; 70:499.</a></li><li><a class="nounderline abstract_t">Stolt P, Källberg H, Lundberg I, et al. Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005; 64:582.</a></li><li><a class="nounderline abstract_t">Webber MP, Moir W, Zeig-Owens R, et al. Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue/recovery workers. Arthritis Rheumatol 2015; 67:1369.</a></li><li><a class="nounderline abstract_t">Miller-Archie SA, Izmirly PM, Berman JR, et al. Systemic Autoimmune Disease Among Adults Exposed to the September 11, 2001 Terrorist Attack. Arthritis Rheumatol 2020; 72:849.</a></li><li><a class="nounderline abstract_t">Li X, Sundquist J, Sundquist K. Socioeconomic and occupational risk factors for rheumatoid arthritis: a nationwide study based on hospitalizations in Sweden. J Rheumatol 2008; 35:986.</a></li><li><a class="nounderline abstract_t">Parks CG, Meyer A, Beane Freeman LE, et al. Farming tasks and the development of rheumatoid arthritis in the agricultural health study. Occup Environ Med 2019; 76:243.</a></li><li><a class="nounderline abstract_t">Ebel AV, Lutt G, Poole JA, et al. Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid Arthritis. Arthritis Rheumatol 2021; 73:392.</a></li><li><a class="nounderline abstract_t">Ying D, Schmajuk G, Trupin L, Blanc PD. Inorganic Dust Exposure During Military Service as a Predictor of Rheumatoid Arthritis and Other Autoimmune Conditions. ACR Open Rheumatol 2021; 3:466.</a></li><li><a class="nounderline abstract_t">Tang B, Liu Q, Ilar A, et al. Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking. Ann Rheum Dis 2023; 82:316.</a></li><li><a class="nounderline abstract_t">De Roos AJ, Koehoorn M, Tamburic L, et al. Proximity to traffic, ambient air pollution, and community noise in relation to incident rheumatoid arthritis. Environ Health Perspect 2014; 122:1075.</a></li><li><a class="nounderline abstract_t">Hart JE, Laden F, Puett RC, et al. Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ Health Perspect 2009; 117:1065.</a></li><li><a class="nounderline abstract_t">Hart JE, Källberg H, Laden F, et al. Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study. Ann Rheum Dis 2013; 72:888.</a></li><li><a class="nounderline abstract_t">Hart JE, Källberg H, Laden F, et al. Ambient air pollution exposures and risk of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013; 65:1190.</a></li><li><a class="nounderline abstract_t">Lee YC, Agnew-Blais J, Malspeis S, et al. Post-Traumatic Stress Disorder and Risk for Incident Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2016; 68:292.</a></li><li><a class="nounderline abstract_t">O'Donovan A, Cohen BE, Seal KH, et al. Elevated risk for autoimmune disorders in iraq and afghanistan veterans with posttraumatic stress disorder. Biol Psychiatry 2015; 77:365.</a></li><li><a class="nounderline abstract_t">Polinski KJ, Bemis EA, Feser M, et al. Perceived Stress and Inflammatory Arthritis: A Prospective Investigation in the Studies of the Etiologies of Rheumatoid Arthritis Cohort. Arthritis Care Res (Hoboken) 2020; 72:1766.</a></li><li><a class="nounderline abstract_t">de Jong HJ, Klungel OH, van Dijk L, et al. Use of statins is associated with an increased risk of rheumatoid arthritis. Ann Rheum Dis 2012; 71:648.</a></li><li><a class="nounderline abstract_t">Tascilar K, Dell'Aniello S, Hudson M, Suissa S. Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study. Arthritis Rheumatol 2016; 68:2603.</a></li><li><a class="nounderline abstract_t">van Boheemen L, Turk S, Beers-Tas MV, et al. Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial. RMD Open 2021; 7.</a></li><li><a class="nounderline abstract_t">Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007; 146:797.</a></li><li><a class="nounderline abstract_t">Rantapää-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48:2741.</a></li><li><a class="nounderline abstract_t">Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50:380.</a></li><li><a class="nounderline abstract_t">Sokolove J, Bromberg R, Deane KD, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 2012; 7:e35296.</a></li><li><a class="nounderline abstract_t">Shadick NA, Cook NR, Karlson EW, et al. C-reactive protein in the prediction of rheumatoid arthritis in women. Arch Intern Med 2006; 166:2490.</a></li><li><a class="nounderline abstract_t">Sparks JA, Iversen MD, Yu Z, et al. Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial. Arthritis Care Res (Hoboken) 2018; 70:823.</a></li><li><a class="nounderline abstract_t">Bos WH, Dijkmans BA, Boers M, et al. Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial. Ann Rheum Dis 2010; 69:571.</a></li><li><a class="nounderline abstract_t">Gerlag DM, Safy M, Maijer KI, et al. Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study. Ann Rheum Dis 2019; 78:179.</a></li><li><a class="nounderline abstract_t">Krijbolder DI, Verstappen M, van Dijk BT, et al. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet 2022; 400:283.</a></li><li class="breakAll">Deane KD, Striebich C, Feser M, et al. Hydroxychloroquine does not prevent the future development of rheumatoid arthritis in a population with baseline high levels of antibodies to citrullinated protein antigens and absence of inflammatory arthritis: Interim analysis of the StopRA trial. Abstract and oral presentation, American College of Rheumatology Convergence, Philadelphia, United States, November 2022.</li><li><a class="nounderline abstract_t">Cope A, Jasenecova M, Vasconcelos J, et al. OP0130 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT (APIPPRA) TRIAL. Ann Rheum Dis 2023; 82:86.</a></li></ol></div><div id="topicVersionRevision">Topic 7519 Version 36.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24550173" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20191579" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28455559" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23281173" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2786329" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : High incidence and prevalence of rheumatoid arthritis in Pima Indians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21360492" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28064207" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16249225" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17299844" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24973898" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9627017" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22425941" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20155830" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29037522" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Rheumatoid arthritis and risk of chronic obstructive pulmonary disease or asthma among women: A marginal structural model analysis in the Nurses' Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29438604" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28885321" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Bone fracture risk in patients with rheumatoid arthritis: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26271620" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26097231" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26473946" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses' Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21953343" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Disability in rheumatoid arthritis in the era of biological treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24285493" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28365576" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22459416" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36331101" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19908947" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Societal cost of rheumatoid arthritis patients in the US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23072761" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23897126" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24390342" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Genetics of rheumatoid arthritis contributes to biology and drug discovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2446635" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22286218" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29967194" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10325661" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9588732" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The influence of sex on the phenotype of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25926142" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15843455" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36974634" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19174392" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16385494" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19151010" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36149365" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Influence of Smoking on Disease Activity and Quality of Life in Patients With Rheumatoid Arthritis: Results From a Swedish Case-Control Study With Longitudinal Follow-Up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29724731" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34406709" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Passive Smoking Throughout the Life Course and the Risk of Incident Rheumatoid Arthritis in Adulthood Among Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30124939" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Passive smoking in childhood increases the risk of developing rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18413445" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24449573" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26017630" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26155788" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23607815" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Cigarette smoking and smoking cessation in relation to risk of rheumatoid arthritis in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30790475" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Impact and Timing of Smoking Cessation on Reducing Risk of Rheumatoid Arthritis Among Women in the Nurses' Health Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12922955" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22782847" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24729427" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11838841" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23940215" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25267142" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Fish consumption and risk of rheumatoid arthritis: a dose-response meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28137914" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Long-term dietary quality and risk of developing rheumatoid arthritis in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25251857" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Mediterranean diet and incidence of rheumatoid arthritis in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30092814" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10913061" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11817612" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14613266" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Coffee consumption and risk of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12578805" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20534819" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17288585" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15593211" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25030783" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17666449" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14730601" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25884929" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25890172" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15529351" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18477739" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28818831" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Oral contraceptives, breastfeeding and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21972241" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Early menopause is an independent predictor of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28085997" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Association Between Menopausal Factors and the Risk of Seronegative and Seropositive Rheumatoid Arthritis: Results From the Nurses' Health Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18311749" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23553100" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24782175" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20595268" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : A prospective study of periodontal disease and risk of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26426533" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Rheumatoid Arthritis Risk Associated with Periodontitis Exposure: A Nationwide, Population-Based Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22183986" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26214836" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27855721" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The lung microbiota in early rheumatoid arthritis and autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22736291" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22576262" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27974664" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24192039" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27333153" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36288282" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16508937" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2472638" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26416719" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19674985" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33648960" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Onset of rheumatoid arthritis after COVID-19: coincidence or connected?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33748780" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Arthritis after SARS-CoV-2 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15814575" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16091399" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28795508" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Occupation and Risk of Developing Rheumatoid Arthritis: Results From a Population-Based Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15319232" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25779102" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue/recovery workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31762219" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Systemic Autoimmune Disease Among Adults Exposed to the September 11, 2001 Terrorist Attack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18464310" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Socioeconomic and occupational risk factors for rheumatoid arthritis: a nationwide study based on hospitalizations in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30760605" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Farming tasks and the development of rheumatoid arthritis in the agricultural health study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33058561" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34085777" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Inorganic Dust Exposure During Military Service as a Predictor of Rheumatoid Arthritis and Other Autoimmune Conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36600175" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24905961" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Proximity to traffic, ambient air pollution, and community noise in relation to incident rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19654914" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Exposure to traffic pollution and increased risk of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22833374" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23401426" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Ambient air pollution exposures and risk of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26239524" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Post-Traumatic Stress Disorder and Risk for Incident Rheumatoid Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25104173" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Elevated risk for autoimmune disorders in iraq and afghanistan veterans with posttraumatic stress disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31600025" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Perceived Stress and Inflammatory Arthritis: A Prospective Investigation in the Studies of the Etiologies of Rheumatoid Arthritis Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21979000" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Use of statins is associated with an increased risk of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27273914" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33685928" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17548411" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14558078" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14872479" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22662108" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17159015" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : C-reactive protein in the prediction of rheumatoid arthritis in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29024454" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19363022" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30504445" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35871815" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35871815" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : OP0130 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT (APIPPRA) TRIAL</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
